Search results for gen

Greenpeace commissioned ICF International to conduct this comparative analysis of renewable generation requirements under the proposed H.R. 2454 (Waxman-Markey) and renewable generation requirements under existing state standards. The resulting report shows that demand for renewable generation under a federal standard falls short of demand projected under existing state programs.

New types of guidelines needed to protect whales from ocean noise.

Planting genetically engineered (GE) trees poses potentially devastating environmental risks.

Climate change is a key challenge that needs to be tackled by competitive eco-technologies. The European Union has played a leading role in defining the Kyoto Protocol. The forthcoming implementation of the emissions trading instrument will pave the way to greater use of renewable sources and to more rational use of energy. Photovoltaic technology, which converts the sun’s energy directly into electricity, will contribute to the reduction of emissions in the medium to long term, not only through cleaner projects in Europe, but also in developing countries through the transfer of technology. This EPIA / Greenpeace blueprint traces possible future developments in the photovoltaic sector over the coming decades, foreseeing significant benefits for the environment, but also for society: the photovoltaic sector might employ more than 2 million people by 2020.

This briefing examines the development of genetically engineered (GE) fish, which could soon be produced on a commercial scale.

The European Union implemented new labelling and traceability legislation for genetically modified food, feed and ingredients in April 2004. They are the strictest world-wide. These new rules, which apply to the world's largest single market, will have major repercussions on the future market of all genetically modified crops, vegetables, fruits, food and feed products derived from GMOs. This document outlines the implications of the new regulation.

The patenting of living organisms continues to be extremely controversial in Europe. Large sections of the general public and politicians continue to reject the patenting of genes and living organisms. This document outlines the social and economic reasons repercussions of using gene patents.